Genepod

February 2016: Cystic Fibrosis in Africa: not a Caucasian-only disease.

March 2016: New and Old Quandaries in Newborn Screening.

April 2016: Investigating the lower risk of solid tumors in Down Syndrome.

May 2016: Diversity Matters – A global atlas of human malformation.

June 2016: The promise of CRISPR: science fact vs. science fiction.

July 2016: The real father of Precision Medicine.

August 2016: New Guidelines for Noninvasive Prenatal Screening from the ACMG.

September 2016: Getting more from Non-Invasive Prenatal Screening.

October 2016: An RCT evaluating simvistatin for treatment of Smith-Lemli-Optiz Syndrome.

November 2016: Updating “The List” – The ACMG 56 is now the ACMG 59.

December 2016: Making Precision Medicine Work.

January 2017: The cost and burden of rare diseases.

February 2017: Screening the Ashkenazi Jewish population for BRCA mutations.

March 2017: Public health and CPT1A variants.

April 2017: NIPS in the Real World.

May 2017: Whole Exome Sequencing...the right, cost effective test in the right clinical situation.

June 2017: Prenatal exome sequencing.

July 2017: Making sense of a deluge of variants: harnessing the power of community.

August 2017: Extending Whole Exome Sequencing to the prenatal period.

September 2017: Moving therapeutics ahead in Genomics: response to imatinib in infantile myofibromatosis.